Skip to content
Cash Flow Statement · TASI 8060

Walaa Cooperative Insurance Co.
Cash and cash equivalents at period end · Insurance operations history.

Cash and cash equivalents at the end of each reporting period. Figures apply to insurance operations. Explore 22 reported observations from 2015 to 2022, with every value linked to its official evidence.

Coverage2015–202222 source-linked periods
Annual history7annual reporting periods
Interim history15quarterly or year-to-date periods
StatementCash Flow Statementas reported by the issuer
Annual series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2021IFRS 4Cash and cash equivalents at period end · Insurance operations322.88M SAR
Cash and cash equivalents at period end · Insurance operations0200M400M600M800M2015201620172018201920202021
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations415.21M SAR
Cash and cash equivalents at period end · Insurance operations0200M400M600M800M20182019202020212022
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations555.28M SAR
Cash and cash equivalents at period end · Insurance operations0200M400M600M800M20182019202020212022
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations543.78M SAR
Cash and cash equivalents at period end · Insurance operations0200M400M600M800M20182019202020212022
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20222022-09-30543,7772022-01-01 to 2022-09-30543.78M SARCash and cash equivalents at end of periodOfficial p. 10 ↗Open statement →
H1 / Q2 20222022-06-30555,2752022-01-01 to 2022-06-30555.28M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20222022-03-31415,2122022-01-01 to 2022-03-31415.21M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20212021-12-31322,8832021-01-01 to 2021-12-31322.88M SARCash and cash equivalents at end of periodOfficial source ↗Related official filing ↗Open statement →
9M / Q3 20212021-09-30454,8792021-01-01 to 2021-09-30454.88M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20212021-06-30516,0322021-01-01 to 2021-06-30516.03M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20212021-03-31566,7752021-01-01 to 2021-03-31566.78M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20202020-12-31687,2972020-01-01 to 2020-12-31687.3M SARCash and cash equivalents at end of periodOfficial source ↗Related official filing ↗Open statement →
9M / Q3 20202020-09-30713,9922020-01-01 to 2020-09-30713.99M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20202020-06-30673,0032020-01-01 to 2020-06-30673M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20202020-03-31683,0472020-01-01 to 2020-03-31683.05M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20192019-12-31560,9252019-01-01 to 2019-12-31560.93M SARCash and cash equivalents at end of periodOfficial source ↗Related official filing ↗Open statement →
9M / Q3 20192019-09-30467,0482019-01-01 to 2019-09-30467.05M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
H1 / Q2 20192019-06-30540,2012019-01-01 to 2019-06-30540.2M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20192019-03-31477,1632019-01-01 to 2019-03-31477.16M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
FY 20182018-12-31654,0062018-01-01 to 2018-12-31654.01M SARCash and cash equivalents at end of periodOfficial source ↗Related official filing ↗Open statement →
9M / Q3 20182018-09-30646,6362018-01-01 to 2018-09-30646.64M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20182018-06-30269,9792018-01-01 to 2018-06-30269.98K SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20182018-03-31292,4772018-01-01 to 2018-03-31292.48M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20172017-12-31289,504,8762017-01-01 to 2017-12-31289.5M SARالنقد وما في حكمه في نهاية السنةالنقد وما في حكمه في نهاية السنةNote 4Signed copy p. 14 ↗Related official filing ↗Open statement →
FY 20162016-12-31594,417,6662016-01-01 to 2016-12-31594.42M SARCash and cash equivalents at the end of the yearالنقد وما في حكمه في نهاية السنةNote 4Signed copy p. 10 ↗Related official filing ↗Open statement →
FY 20152015-12-31373,227,3692015-01-01 to 2015-12-31373.23M SARCash and cash equivalents at the end of the yearالنقد وما في حكمه في نهاية السنةNote 4Signed copy p. 10 ↗Related official filing ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

ولاء — Cash and cash equivalents at period end · Insurance operations

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.